孕妇血液内母酶水平作为怀孕期间高血压疾病的预测生物标志物:一项前性队列研究
Mustafa Can Sivas1,2, Handan Turhan Karakus3, Serkan Ozbey3
1Department of Obstetrics and Gynecology, Republic of Türkiye Ministry of Health Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye. can.sivas@windowslive.com.
与健康对照组相比,孕妇患有先兆子 (PE) 或妊娠高血压 (GHT) 的孕妇的纠正内分泌酶 (cEndo) 水平较低. 母亲血液cEndo可能有助于区分高血压疾病与健康怀孕,但不能区分PE和GHT.
科学领域:
- 生殖医学 生殖医学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 生物化学 生物化学
背景情况:
- 孕前 (PE) 和妊娠高血压 (GHT) 是严重的妊娠并发症,与不充分的螺旋动脉和热囊细胞重塑有关.
- 内分泌酶是参与血管和胎盘重塑过程的酶,对于健康的怀孕至关重要.
研究的目的:
- 为了研究PE,GHT和健康怀孕的妇女之间的母体血液内母酶水平的差异.
- 评估血内分泌酶值作为PE和GHT的诊断或预测标记物的潜力.
主要方法:
- 酶相关免疫吸收试验 (ELISA) 用于测量90名孕妇 (30PE,30GHT,30健康) 血中的内分泌酶水平.
- 对内分泌酶值进行了对白蛋白水平的校正,以确定校正的内分泌酶 (cEndo) 值.
- 统计分析比较了不同组的cEndo水平,并将其与血压测量相关联.
主要成果:
- 两组之间没有发现未经纠正的血液内分酶水平的显著差异.
- 与健康的孕妇相比,PE和GHT组的纠正内分泌酶 (cEndo) 值显着较低.
- 在cEndo值和静缩和静缩血压之间观察到显著的负线性关系.
结论:
- 孕妇血液中的cEndo水平显示出作为生物标志物的潜力,以区分妊娠高血压疾病 (PE + GHT) 与健康怀孕.
- cEndo水平似乎不有效地区分孕前和妊娠高血压.
- 建议对更大的队列进行进一步的研究,以验证这些发现.
更多相关视频
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
相关概念视频
Hormonal Regulation
Hypertension III: Clinical Manifestations and Diagnostic Studies
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
